Mes: septiembre 2020

BRONX, New York, Sept. 25, 2020 /PRNewswire-HISPANIC PR WIRE/ — A study from Montefiore Health System and Albert Einstein College of Medicine published today in JAMA Network Open found that among 5,902 ethnically diverse COVID-19-positive patients admitted to Montefiore Medical Center, the outcomes for Black and Hispanic patients relative to their White counterparts were the same or better.

The study shows that Black and Hispanic patients who were hospitalized with COVID-19 presented with more pre-existing conditions, also known as comorbidities, as well as other risk factors. However, researchers found that Black and Hispanic patients had survival rates at least as good as their non-Hispanic White counterparts, when controlling for age, sex, socioeconomic status and comorbidities. Similar data trends have been shown in patients hospitalized in other major health systems in Louisiana and the Midwest.

«It is well-documented that communities of color have shouldered the heaviest burden of COVID-19 in the United States, and there have been many explanations offered for why that is the case,» said Andrew D. Racine, M.D., Ph.D., system senior vice president and chief medical officer at Montefiore and professor of pediatrics at Einstein. «We discovered, somewhat surprisingly, that Black and Hispanic patients, when hospitalized, had similar or slightly better survival outcomes compared to White patients.»

According to the study’s authors, these results are important because they suggest that «access to the services available in comprehensive health care environments may attenuate, if not eliminate, racial/ethnic differentials in COVID-19 mortality rates.» The study results suggest that, across racial and ethnic groups, higher mortality rates were primarily driven by older age and the presence of multiple comorbidities, including chronic diseases such as obesity, diabetes and cardiovascular disease that are prevalent in Black and Hispanic communities served by Montefiore | Einstein.

Black and Hispanic patients were found more likely to require hospital stays than their White counterparts and had a higher proportion of two or more medical comorbidities–38% and 43% respectively–compared to their White counterparts at 34%. «For patients in this study, the influence of race and ethnicity on COVID outcomes stopped at the hospital door,» explained Dr. Racine.

«The fact that racial disparities may be lessened or eliminated when people with COVID-19 enter a hospital is a stark reminder that we need to increase our focus on what is happening outside our hospitals,» said Rafi Kabarriti, M.D., attending physician, Montefiore and assistant professor of radiation oncology at Einstein.  «This includes better access to primary care, and education about preventing and effectively managing chronic diseases, including obesity, cardiovascular disease, diabetes, renal disease, and dementia.»

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 11 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2019-20 academic year, Einstein is home to 724 M.D. students, 158 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,800 full-time faculty members located on the main campus and at its clinical affiliates. In 2019, Einstein received more than $178 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Photo – https://mma.prnewswire.com/media/1281533/Racine_Andrew_MD_2012_08_2_SELECT.jpg 
Photo – https://mma.prnewswire.com/media/1281534/Kabarriti_Rafi_MD_LC_2015_08_2.jpg
Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg
Logo – https://mma.prnewswire.com/media/1281532/Albert_Einstein_College_of_Medicine.jpg

SOURCE Montefiore Health System; Albert Einstein College of Medicine

The online seminar, in alliance with Fernando Anzures and EXMA BE ON, is aimed at entrepreneurial leaders, influencers, professionals from all sectors, students and anyone in the process of reinvention.

MIAMI, Sept. 25, 2020 /PRNewswire-HISPANIC PR WIRE/ — Deepak Chopra and John Maxwell, world leaders in mindfulness and leadership, respectively, will join Ismael Cala, on October 16 and 17, in «The Business of Being You. Seminar on Entrepreneurship».

«In difficult times, we demonstrate our leadership capabilities. That is why this is the time for entrepreneurship. I am happy to share this event with Ismael Cala and his guests,» said John Maxwell.

The largest entrepreneurship seminar in the Americas will help participants develop an entrepreneurial mindset to take action. Especially under the current circumstances, where the Covid-19 pandemic has created uncertainty in business, but also new opportunities.

«The Business of Being You. Entrepreneurship Seminar»  will address topics such as entrepreneurship, marketing, finance, sales, mindful leadership, technology and future vision.

In addition to those already mentioned, the experts will include:

-Mario and Lorenzo Hernández, businessmen
–Jacques Giraud, master Coach and academic director of Cala Enterprises
–Valeria Hinojosa, founder of WaterThruSkin
–Juan M. Barrientos, chef at El Cielo
–James Tahhan, chef and triple Emmy Award winner
–Javier Meza, CMO Sparkling Coca-Cola Company
-Beto Pérez, creator and co-founder of Zumba®
-Vilma Núñez, CEO Convierte Más Agency
–Darys Estrella, expert on finance, the stock market, and sustainability
-Calle and Poche, influencers
–Alex Kei, advisor to consultants, authors and executives
–Santiago Siri, CEO of Democracy.Earth and technology expert
–Adriana Cisneros, CEO Grupo Cisneros

The seminar, in alliance with Fernando Anzures and EXMA BE ON, is aimed at entrepreneurial leaders, influencers, professionals from all sectors, students and anyone in the process of transformation and reinvention.

Date: October 16-17, 2020
Medium: Online
Info: +1 (305) 360 9940 – conecta@calapresenta.com 
Registration: https://seminarionst.ismaelcala.com/

ABOUT ISMAEL CALA

Life and business strategist. For five and a half years he was the prime-time host of «Cala» on CNN en Español. Businessman and social entrepreneur. He is the author of eight bestsellers on themes of leadership, entrepreneurship and personal development, including El poder de escuchar (‘The Power of Listening’), and Despierta con Cala (‘Wake Up with Cala’). Cala was born in Santiago de Cuba in 1969 and holds a degree in Art History from Oriente University. He graduated from the School of Communication at York University in Toronto and has a diploma from Seneca College in Television Production. He is the President and founder of the Cala Enterprises Corporation and the Ismael Cala Foundation.

SOURCE Cala Enterprises

MIAMI, Sept. 25, 2020 /PRNewswire-HISPANIC PR WIRE/ —

What is the lawsuit about?  The lawsuit claims that at times Walmart improperly labeled «Weighted Goods» when it reduced the price of those goods as they neared their expiration dates, allegedly causing instances where customers were overcharged for certain reduced-priced perishable goods and did not receive the full value of the goods purchased.  Walmart denies these allegations and all liability regarding the claims asserted in the lawsuit. Neither the Court nor a jury have considered or decided the merits of the allegations in the lawsuit. The parties have negotiated and entered into the proposed Settlement to avoid the risk, uncertain outcome, expense and distraction of continued litigation.

Who is included?  The Court has decided that any person who purchased Weighted Goods from Walmart in the United States from February 13, 2015 to August 26, 2020 whose Weighted Goods’ unit sale price was not accurately reflected in the final sale price, is considered a Settlement Class Member.  «Weighted Goods» means beef, pork, poultry, fish and other types of goods marked with unit pricing and sold accordingly thereto.

What does the Settlement provide?  The Settlement provides for the following relief: 

A. Walmart will fund a Qualified Settlement Fund («QSF») of between $4,500,000 and, depending on the number of valid claims submitted, up to $9,500,000.  The QSF will be used to pay Settlement Class Members who submit a claim, and pay for the costs of notice and administration of the Settlement, attorneys’ fees and litigation expenses, and a service award to the Class Representative.

B. In exchange for the payment, the Class Representative and each Settlement Class Member who has not validly and timely requested exclusion from the Settlement will have fully, finally, and forever released any and all claims against Walmart relating to the nature of the lawsuit. 

What are your options?  Each Settlement Class Member is entitled to a monetary payment under the Settlement, but the actual amount will not be known until all Claims have been processed. To qualify for a payment from the Settlement, you must submit a Claim Form before January 8, 2021.  If you do not want a payment and do not want to be legally bound by the Settlement, you must exclude yourself with a timely and valid «Opt Out Letter» postmarked no later than November 4, 2020.  Unless you exclude yourself, you give up the right to sue Walmart for the same claims that this Settlement resolves.  You must exclude yourself from this Settlement Class to continue your own lawsuit.  If you are a Settlement Class Member, and have not excluded yourself from the Settlement, you can object to the Settlement if you don’t like any part of it.  This objection must be postmarked no later than November 4, 2020.  The Court will hold a Fairness Hearing on February 26, 2021, to consider whether the Settlement is fair, reasonable and adequate and whether to approve attorneys’ fees not to exceed $2,375,000 and litigation expenses not to exceed $100,000, both from the QSF.  You may appear at the Fairness Hearing, but you are not required to attend. You may also hire your own attorney, at your own expense, to appear or speak for you at the hearing.  The Notice of Class Settlement available at the website explains how to ask the Court for permission to speak at the hearing.  For more information, call 1-855-424-1334 or visit www.WalmartWeightedGoodsSettlement.com. 

SOURCE United States District Court for Southern District of Florida, Miami Division